Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia.

Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia.
复制标题

DOI:
10.1080/10428194.2022.2102621
复制
发表时间:
2022-12
影响因子:
2.6
通讯作者:
--
中科院分区:
医学4区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

共审查了548例诊断为急性淋巴细胞白血病的患者(年龄范围:1-22岁,60.4%为西班牙裔,55.8%为男性)的培门冬酯相关超敏反应(14.8%)、高胆红素血症(9.7%)、静脉血栓栓塞(VTE,9.7%)和胰腺炎(5.3%)。比值比(OR)和95%置信区间(CI)评估了临床因素与每种毒性、累积毒性数量和使用k-模式分析确定的毒性簇之间的相关性。大多数(68.9%)未发生任何毒性,24.6%发生一次毒性,6.3%发生两次或两次以上毒性。年龄>10岁与高胆红素血症有关(OR = 3.83; 95%CI:1.64-8.95),胰腺炎(OR = 3.72; 95% CI:1.29-10.68),VTE(OR = 4.65; 95%CI:1.96-11.02),累积毒性负荷(OR = 3.28,95%CI:1.97-5.47);高危治疗伴超敏反应(OR 2.25,95%CI:1.25-4.05);超重伴累积毒性负荷(OR = 1.76,95%CI:1.20-2.57)。确定了8种独特的毒性特征。年龄较大、超重和治疗强度导致了哌醋甲酯相关毒性。
A total of 548 patients (age range: 1–22 years, 60.4% Hispanic, 55.8% male) diagnosed with acute lymphoblastic leukemia were reviewed for pegaspargase-associated hypersensitivity (14.8%), hyperbilirubinemia (9.7%), venous thromboembolism (VTE, 9.7%), and pancreatitis (5.3%). Odds ratios (OR) and 95% confidence intervals (CI) evaluated associations between clinical factors and each toxicity, cumulative number of toxicities, and toxicity clusters identified using k-mode analysis. Most (68.9%) did not experience any toxicity, 24.6% experienced one toxicity, and 6.3% two or more. Age >10 years was associated with hyperbilirubinemia (OR = 3.83; 95% CI: 1.64–8.95), pancreatitis (OR = 3.72; 95% CI: 1.29–10.68), VTE (OR = 4.65; 95% CI: 1.96–11.02), and cumulative toxicity burden (OR = 3.28, 95% CI: 1.97–5.47); high-risk therapy with hypersensitivity (OR 2.25; 95% CI 1.25–4.05); and overweight with cumulative toxicity burden (OR = 1.76, 95% CI: 1.20–2.57). Eight unique toxicity profiles were identified. Older age, overweight, and treatment intensity contribute to pegaspargase-associated toxicities.
DOI: 10.1002/cpt.629
发表时间: 2017-07
影响因子: 6.7
作者:
Liu Y;Fernandez CA;Smith C;Yang W;Cheng C;Panetta JC;Kornegay N;Liu C;Ramsey LB;Karol SE;Janke LJ;Larsen EC;Winick N;Carroll WL;Loh ML;Raetz EA;Hunger SP;Devidas M;Yang JJ;Mullighan CG;Zhang J;Evans WE;Jeha S;Pui CH;Relling MV
通讯作者: Relling MV
DOI: 10.1158/1055-9965.epi-19-0941
发表时间: 2020-06
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者:
通讯作者: --
DOI: 10.1634/theoncologist.12-8-991
发表时间: 2007-01-01
期刊: ONCOLOGIST
影响因子: 5.8
作者:
Dinndorf, Patricia Anne;Gootenberg, Joseph;Pazdur, Richard
通讯作者: Pazdur, Richard
DOI: 10.1200/jco.20.00494
发表时间: 2021-05-01
影响因子: 45.3
作者:
Angiolillo, Anne L.;Schore, Reuven J.;Hunger, Stephen P.
通讯作者: Hunger, Stephen P.
DOI: 10.1200/jco.19.03024
发表时间: 2020-06-10
影响因子: 45.3
作者:
Gupta, Sumit;Wang, Cindy;Devidas, Meenakshi
通讯作者: Devidas, Meenakshi